Hope for Veterans Immune Checkpoint Inhibitors for the Treatment of BCC, cSCC, and NSCLC

Welcome to the AVAHO immunooncology resource website. Here you can view numerous animations on non-melanoma skin cancer and non-small cell lung cancer, including programs on their pathophysiology, interactions with the immune system, and the mechanism of action of immunotherapies in these diseases.

Register Here
This activity is provided by Med Learning Group.
This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM).
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2022 Med Learning Group. Built by Divigner. All Rights Reserved.

NSCLC HD Visual Learning

Non-Small Cell Lung Cancer
  • 7700 veterans in the VA are diagnosed with lung cancer each year
  • An estimated 900,000 remain at risk due to age, smoking, and other environmental exposures during and after military service
  • Military service members are 25% more likely to receive a lung cancer diagnosis than the general population.
  • The survival rate among veterans has been historically lower than the general population.

US Department of Veterans Affairs (VA). VA and GO2 Foundation https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5468

Lung Cancer Center. Lung Cancer in the Military. https://www.lungcancercenter.com/who-lung-cancer-affects/military/

Customize your NSCLC Poster

cSCC HD Visual Learning

  • Second most common form of skin cancer
  • Lifetime risk of 9% to 14% for men and 4% to 9% for women.
  • Greater mortality rate than melanoma

Sung H, et al. CA Cancer J Clin. 2021: 71: 209- 249. Verkouteren JAC, et al. Br J Dermatol. 2017;177:359-372. Olsen CM, et al. Aust N Z J Public Health. 2015;39:471-476. Karia PS, et al. J Am Acad Dermatol. 2013;68:957-966. Weinberg AS, et al. Dermatol Surg. 2007;33:885-899. Kim JYS, et al. J Am Acad Dermatol. 2018;78:560-578.

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Cutaneous Squamous Cell Carcinoma (cSCC)
Resources and Tools
Customize your cSCC Poster

BCC HD Visual Learning

  • Most common skin cancer
  • About 80% of all skin cancers
  • Increasing rates, particularly in young women due to tanning
  • Two times the risk of progressing to melanoma

Sung H, et al. CA Cancer J Clin. 2021: 71: 209- 249. Verkouteren JAC, et al. Br J Dermatol. 2017;177:359-372. Olsen CM, et al. Aust N Z J Public Health. 2015;39:471-476. Karia PS, et al. J Am Acad Dermatol. 2013;68:957-966. Weinberg AS, et al. Dermatol Surg. 2007;33:885-899. Kim JYS, et al. J Am Acad Dermatol. 2018;78:560-578.

Click on the button below for more resources and tools that aims to provide clinicians up-to-date information on Basal Cell Carcinoma (BCC)
Resources and Tools
Customize your BCC Poster